1 Gram	Negotiable

Min.Order :1 Gram
Purity: 99%
Payment Terms : L/C,T/T,,MoneyGram

Keywords

Atosiban Acetate/Vapreotide Acetate CAS 90779-69-4 custom peptides/Somatostatin Acetate

Quick Details

Appearance:white powder
Application:peptide,custom peptides,cosmetic peptides,GMP peptides,catalog peptides,oxytocin,leuprorelin,Glatiramer,Bivalirudin,Triptorelin,Terlipressin Desmopressin,Carbetocin,Teriparatide ,Eptifibatide,Iparmore
PackAge:1G/BAG,10G/BAG
ProductionCapacity:20|Kilogram|Month
Storage:-20℃
Transportation:2-8degree

Superiority:

Atosiban Acetate

Be the first to review this product

IN STOCK

$307.70

QUICK OVERVIEW

Product Name Atosiban Acetate;
Cas No. 90779-69-4;
Sequence Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Cyclic1-6);
Molecular Formula C43H67N11O12S2;
Molar Mass 994.199 g/mol;
Purity ≥98%;
Impurity ≤0.5% ;
Storage Temperature 2-8℃;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.

Atosiban Acetate can postpone its imminent premature birth.

Mechanism of action: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.

Originator Company: Ferring Pharmaceuticals

Dosage for formulation: 7.5mg/ml

Generic API process in our company: Atosiban Acetate is one of our main peptide projects, related documents will be submitted to the international FDA.

*Price

Details:

Atosiban Acetate

Be the first to review this product

IN STOCK

$307.70

QUICK OVERVIEW

Product Name Atosiban Acetate;
Cas No. 90779-69-4;
Sequence Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Cyclic1-6);
Molecular Formula C43H67N11O12S2;
Molar Mass 994.199 g/mol;
Purity ≥98%;
Impurity ≤0.5% ;
Storage Temperature 2-8℃;
Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement.

Atosiban Acetate can postpone its imminent premature birth.

Mechanism of action: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua.

Originator Company: Ferring Pharmaceuticals

Dosage for formulation: 7.5mg/ml

Generic API process in our company: Atosiban Acetate is one of our main peptide projects, related documents will be submitted to the international FDA.

*Price